Abstract:Metabolic reprogramming at a cellular level contributes to many diseases including cancer, yet few assays are capable of measuring metabolic pathway usage by individual cells within living samples. Here, autofluorescence lifetime imaging is combined with single-cell segmentation and machine-learning models to predict the metabolic pathway usage of cancer cells. The metabolic activities of MCF7 breast cancer cells and HepG2 liver cancer cells were controlled by growing the cells in culture media with specific substrates and metabolic inhibitors. Fluorescence lifetime images of two endogenous metabolic coenzymes, reduced nicotinamide adenine dinucleotide (NADH) and oxidized flavin adenine dinucleotide (FAD), were acquired by a multi-photon fluorescence lifetime microscope and analyzed at the cellular level. Quantitative changes of NADH and FAD lifetime components were observed for cells using glycolysis, oxidative phosphorylation, and glutaminolysis. Conventional machine learning models trained with the autofluorescence features classified cells as dependent on glycolytic or oxidative metabolism with 90%–92% accuracy. Furthermore, adapting convolutional neural networks to predict cancer cell metabolic perturbations from the autofluorescence lifetime images provided improved performance, 95% accuracy, over traditional models trained via extracted features. Additionally, the model trained with the lifetime features of cancer cells could be transferred to autofluorescence lifetime images of T cells, with a prediction that 80% of activated T cells were glycolytic, and 97% of quiescent T cells were oxidative. In summary, autofluorescence lifetime imaging combined with machine learning models can detect metabolic perturbations between glycolysis and oxidative metabolism of living samples at a cellular level, providing a label-free technology to study cellular metabolism and metabolic heterogeneity.

Deep-Learning Terahertz Single-Cell Metabolic Viability Study

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Deep Learning-Assisted Assessing of Single Circulating Tumor Cell Viability via Cellular Morphology

Study on the Detection Method of Biological Characteristics of Hepatoma Cells Based on Terahertz Time-Domain Spectroscopy.

Single cell imaging with near‐field terahertz scanning microscopy

Detection of In Vivo-like Cells by a Biosensor Chip Based on Metamaterials in Terahertz Regime

Nondestructive, quantitative viability analysis of 3D tissue cultures using machine learning image segmentation

Live-dead assay on unlabeled cells using phase imaging with computational specificity

Label-free spatially maintained measurements of metabolic phenotypes in cells

Bifunctional Nanoprobe for Simultaneous Detection of Intracellular Reactive Oxygen Species and Temperature in Single Cells.

Nanometer Resolution Mass Spectro-Microtomography for In-Depth Anatomical Profiling of Single Cells

Evaluation of a Deep Learning Based Approach to Computational Label Free Cell Viability Quantification

Fast-Training Deep Learning Algorithm for Multiplex Quantification of Mammalian Bioproduction Metabolites via Contactless Short-Wave Infrared Hyperspectral Sensing

Brain Cell Laser Powered by Deep‐Learning‐Enhanced Laser Modes

Terahertz s-SNOM Imaging of a Single Cell with Nanoscale Resolution

Quantitative and long-term cell imaging with computational hyperspectral interferometry

Countermeasure to cell dehydration caused terahertz near-field scanning image deterioration

Multichannel Cell Thermometry System Based on Transparent Platinum Resistance for Real-Time Visual Monitoring Energy Metabolism in Vascular Endothelial Cells

Deep and Dynamic Metabolic and Structural Imaging in Living Tissues